179 related articles for article (PubMed ID: 31285681)
1. Renal cell carcinoma in the Canadian Indigenous population.
Wong ECL; Breau RH; Mallick R; Wood L; Pouliot F; Basappa NS; Tanguay S; Soulières D; So A; Heng D; Lavallée LT; Drachenberg D; Kapoor A
Curr Oncol; 2019 Jun; 26(3):e367-e371. PubMed ID: 31285681
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
4. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis.
Chen K; Huang HH; Aydin H; Tan YH; Lau WK; Cheng CW; Yuen JS
Scand J Urol; 2015 Jun; 49(3):200-4. PubMed ID: 25783025
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
[TBL] [Abstract][Full Text] [Related]
9. Management of comorbidities in diabetics with renal cell carcinoma: past utilization and current outcomes.
Rabey JL; Yin J; Kublas TM; Mashtare T; Ceacareanu AC
J Pharm Pract; 2014 Feb; 27(1):31-9. PubMed ID: 23966283
[TBL] [Abstract][Full Text] [Related]
10. Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting.
Nazha S; Tanguay S; Kapoor A; Jewett M; Kollmannsberger C; Wood L; Bjarnason G; Heng D; Soulières D; Reaume N; Basappa N; Lévesque E; Dragomir A
Curr Oncol; 2018 Dec; 25(6):e576-e584. PubMed ID: 30607126
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).
Weiss VL; Braun M; Perner S; Harz A; Vorreuther R; Kristiansen G; Müller SC; Ellinger J
BJU Int; 2014 Feb; 113(2):209-17. PubMed ID: 24053185
[TBL] [Abstract][Full Text] [Related]
12. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era.
Culp SH; Karam JA; Wood CG
Urol Oncol; 2014 Jul; 32(5):561-8. PubMed ID: 24709415
[TBL] [Abstract][Full Text] [Related]
13. Safety and outcomes of surgical treatment of renal cell carcinoma in the elderly.
O'Malley RL; Hayn MH; Hellenthal NJ; Kim HL; Underwood W; Schwaab T
Can J Urol; 2012 Feb; 19(1):6111-7. PubMed ID: 22316513
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.
Tsimafeyeu I; Zart JS; Chung B
BJU Int; 2013 Jul; 112(1):32-8. PubMed ID: 23746142
[TBL] [Abstract][Full Text] [Related]
16. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma.
Rampersaud EN; Klatte T; Bass G; Patard JJ; Bensaleh K; Böhm M; Allhoff EP; Cindolo L; De La Taille A; Mejean A; Soulie M; Bellec L; Christophe Bernhard J; Pfister C; Colombel M; Belldegrun AS; Pantuck AJ; George D
Urol Oncol; 2014 Jan; 32(1):30.e9-13. PubMed ID: 23422777
[TBL] [Abstract][Full Text] [Related]
17. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of renal cell carcinoma in a cohort of Sri Lankan patients: A case-control study.
Balagobi B; Indika K; Samaraweera WMCK; Wijayarathna KSN; Maddumage HP; Sutharshan K; Suvendran S; Abeygunasekera AM
J Cancer Res Ther; 2019 Mar; 15(Supplement):S91-S96. PubMed ID: 30900628
[TBL] [Abstract][Full Text] [Related]
19. Neovascularity as a prognostic marker in renal cell carcinoma.
Bauman TM; Huang W; Lee MH; Abel EJ
Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, clinical staging, and presentation of renal cell carcinoma.
Decastro GJ; McKiernan JM
Urol Clin North Am; 2008 Nov; 35(4):581-92; vi. PubMed ID: 18992612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
